Quotes 5-day view Delayed Nasdaq
05/11/2022
05/12/2022
05/13/2022
05/16/2022
05/17/2022
Date
33.06(c)
33.44(c)
36.94(c)
36.23(c)
37.16 Last
869 990
734 369
672 249
639 735
250 946 Volume
-2.36% +1.15% +10.47% -1.92% +2.57% Change
Estimated financial data (e) (USD)
Sales 2022
757 M - -
Net income 2022
10,8 M - -
Net cash position 2022
210 M - -
P/E ratio 2022
192x
Yield 2022
-
Sales 2023
1 034 M - -
Net income 2023
38,7 M - -
Net cash position 2023
334 M - -
P/E ratio 2023
84,8x
Yield 2023
-
Capitalization
3 396 M 3 396 M -
EV / Sales 2022
4,21x
EV / Sales 2023
2,96x
Nbr of Employees
312
Free-Float
83,9%
Progyny, Inc. is a benefits management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company provides its benefit through its Smart Cycle approach. The Smart Cycle includes medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition, to its fertility benefits...
All news about PROGYNY, INC.
05/11 TRANSCRIPT : Progyny, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-..CI
05/06 PROGYNY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
.. AQ
05/06 The Broken Brown Egg and Progyny Launch the Awareness, Hope, and Activism Grant™ .. GL
05/06 Berenberg Bank Adjusts Progyny's Price Target to $66 From $70, Maintains Buy Rating MT
05/05 PROGYNY : Q1 Earnings SnapshotAQ
05/05 CORRECTION : Guidance: (pgny) progyny q1 eps $0.05MT
05/05 Earnings Flash (PGNY) PROGYNY Posts Q1 Revenue $172.2M, vs. Street Est of $167.2M MT
05/05 GUIDANCE : (PGNY) PROGYNY Sees Q2 EPS $0.05MT
05/05 TRANSCRIPT : Progyny, Inc., Q1 2022 Earnings Call, May 05, 2022CI
05/05 Progyny, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
05/05 Progyny, Inc. Announces First Quarter 2022 Results GL
05/05 Progyny, Inc. Announces First Quarter 2022 Results AQ
05/05 Progyny, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2022 CI
04/28 Progyny, Inc. to Present at the BofA Securities 2022 Healthcare Conference AQ
04/21 Progyny, Inc. Announces Details for Its First Quarter 2022 Results Report AQ
News in other languages on PROGYNY, INC.
Analyst Recommendations on PROGYNY, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends PROGYNY, INC.
Short Term Mid-Term Long Term Trends Bearish Bearish Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
6
Last Close Price
36,94 $
Average target price
62,83 $
Spread / Average Target
70,1%
Please enable JavaScript in your browser's settings to use dynamic charts.
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
